Benefits of CPAP Machine: Sleep & Health

The benefits of CPAP machine therapy extend well beyond a quieter night's sleep. For people living with obstructive sleep apnoea (OSA), continuous positive airway pressure treatment can restore energy, sharpen concentration, improve mood, and reduce serious long-term health risks including high blood pressure and cardiovascular disease. Whether you have recently been diagnosed or are considering treatment options, understanding what CPAP can do for your sleep, daily functioning, and overall health is an important first step towards making an informed decision about your care.

What does a CPAP machine actually do for your sleep and health?

A CPAP machine delivers pressurised air through a mask to keep the upper airway open, preventing the breathing pauses of obstructive sleep apnoea and restoring normal sleep architecture. NICE NG202 recommends it as first-line treatment for moderate to severe OSAHS.

A CPAP (continuous positive airway pressure) machine treats obstructive sleep apnoea (OSA) by delivering a steady stream of pressurised air through a mask, keeping the upper airway open throughout the night and preventing the repeated breathing pauses that define the condition. During an apnoea episode, the throat muscles relax and partially or fully block the airway, causing oxygen levels to drop and the brain to briefly rouse the sleeper. CPAP eliminates these interruptions by acting as a pneumatic splint for the airway.

The machine draws in room air, filters it, and pressurises it to a level set by a clinician following a sleep study. This pressure is delivered via a tube to a nasal mask, full-face mask, or nasal pillow interface. Modern devices are compact, quiet, and many include auto-adjusting (APAP) technology that varies pressure breath by breath in response to airway resistance.

Because OSA fragments sleep architecture and reduces time spent in restorative deep and REM sleep, effective CPAP use can restore more normal sleep staging. Many people notice improvements in sleep quality within the first few nights of consistent use, though full acclimatisation to the device can take several weeks.

NICE guideline NG202 (Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over 16s) recommends CPAP as the first-line treatment for adults with moderate to severe obstructive sleep apnoea/hypopnoea syndrome (OSAHS), and it is also considered for symptomatic mild OSAHS where it affects quality of life.^[1][2] For some people with mild to moderate OSA, a mandibular advancement device (a custom-fitted oral appliance) may be an appropriate alternative, as recognised in NICE NG202.^[1][2] Lifestyle measures such as weight loss, reducing alcohol intake, and positional therapy are also relevant where applicable and should be discussed with your clinical team.

How can CPAP therapy improve your daily life and energy levels?

CPAP therapy reduces excessive daytime sleepiness, improves concentration, mood, and physical energy, often within the first week of consistent use. People with OSAHS and daytime sleepiness must notify the DVLA and stop driving until symptoms are controlled.

CPAP therapy significantly reduces daytime sleepiness, one of the most disabling symptoms of untreated obstructive sleep apnoea, often within the first week of consistent use. Excessive daytime somnolence in OSA arises because fragmented, non-restorative sleep impairs the brain's ability to consolidate memory, regulate mood, and sustain attention. By restoring uninterrupted sleep, CPAP allows the body to complete its natural sleep cycles properly.

People using CPAP regularly commonly report:

• Improved concentration and mental clarity at work or during daily tasks

• Better mood and reduced irritability, with some studies noting reductions in depressive symptoms

• Greater physical energy, making exercise and everyday activities feel less effortful

• Improved relationship quality, particularly where a partner's sleep was also disrupted by the affected person's snoring or restlessness

Driving safety is a particularly important consideration. If you have OSAHS with excessive daytime sleepiness, you must stop driving and notify the DVLA.^[3] You should not drive until your symptoms are effectively controlled, typically confirmed through CPAP use and medical review. The DVLA's guidance on assessing fitness to drive sets out the notification requirements and the conditions under which driving may resume. If you feel sleepy at the wheel or are concerned about your fitness to drive, seek urgent review from your GP or sleep service.

Occupational performance can also improve markedly. Research has demonstrated gains in executive function, working memory, and reaction time following CPAP initiation, benefits that translate directly into safer and more productive working lives, particularly in safety-critical roles.^[13][14]

Key health benefits of long-term CPAP use backed by evidence

Long-term CPAP use lowers blood pressure, improves insulin sensitivity, and is associated with reduced stroke risk and fewer depressive symptoms. Benefits are most pronounced in people using CPAP for at least four to six hours per night.

Long-term CPAP use is associated with meaningful reductions in cardiovascular risk, blood pressure, and metabolic disturbance in people with obstructive sleep apnoea. Untreated OSA causes repeated cycles of hypoxia and reoxygenation, sympathetic nervous system activation, and systemic inflammation, all of which contribute to hypertension, arrhythmia, and increased risk of cardiovascular events.

Cardiovascular effects: Multiple studies and meta-analyses have demonstrated that CPAP lowers systolic and diastolic blood pressure. The average effect is modest across unselected populations but is more pronounced in people with severe OSA and those with resistant hypertension. Observational data also suggest reductions in the incidence of atrial fibrillation recurrence following cardioversion in people who use CPAP consistently, though randomised trial evidence in this specific area is more limited.^[8][9] Some large randomised trials have found neutral effects on major cardiovascular events, particularly where average nightly CPAP use was low, underscoring the importance of consistent adherence.^[2]

Metabolic health: OSA is closely linked to insulin resistance and type 2 diabetes. CPAP therapy has been shown to improve insulin sensitivity and glycaemic control in some patient groups, though the magnitude of benefit varies and CPAP is not a substitute for diabetes management.^[10][11]

Stroke risk: Observational data indicate that untreated severe OSA is an independent risk factor for stroke.^[12] Long-term CPAP use appears to attenuate this risk, though this remains an active area of research and the evidence base is largely observational.

Mental health: Sustained CPAP use has been associated with reductions in anxiety and depressive symptoms over time, likely reflecting the cumulative benefit of restored sleep quality on neurological and emotional regulation.

It is important to note that most of these benefits are dose-dependent: they are most pronounced in people who use CPAP for at least four to six hours per night on the majority of nights. NICE NG202 and associated evidence reviews provide further detail on the strength of evidence for these outcomes.

Are there any side effects or risks I should know about?

Common side effects include mask discomfort, nasal dryness, and aerophagia, most of which are manageable with clinical guidance. Serious adverse events are rare; do not adjust pressure settings yourself or start CPAP without a clinical diagnosis.

CPAP therapy is generally safe and well tolerated, but a number of side effects are common, particularly during the initial adjustment period, and most can be managed with guidance from a sleep clinic or respiratory physiologist. Understanding these in advance helps people persist through early difficulties rather than abandoning treatment.

Common side effects include:

• Mask discomfort or pressure sores, particularly over the nose bridge, which can often be resolved by adjusting the fit or trying a different mask style

• Nasal congestion, dryness, or rhinorrhoea, frequently improved by using a heated humidifier, which is built into many modern devices

• Aerophagia (air swallowing), which can cause bloating or discomfort and may require a pressure adjustment by your clinical team

• Claustrophobia or anxiety related to wearing the mask, which can be addressed through gradual acclimatisation techniques

• Dry mouth, often a sign that the mouth is opening during sleep, addressable with a chin strap or full-face mask

Less commonly, people may experience sinus or ear discomfort, recurrent nosebleeds, or conjunctival irritation from mask leaks. If any of these occur, contact your sleep service for review.

Do not attempt to adjust your CPAP pressure settings yourself, and do not start CPAP therapy without a clinical diagnosis and proper titration. Incorrect pressure settings can result in ineffective treatment or discomfort, and self-purchasing a device without clinical oversight is not recommended.

Serious adverse events from CPAP are rare. If you experience chest pain, worsening breathlessness, or symptoms that concern you, contact your GP or call NHS 111 for advice. Any suspected device malfunction or adverse incident associated with your CPAP equipment should be reported to the MHRA via the Yellow Card scheme (yellowcard.^[15]mhra.gov.uk), which covers medical devices as well as medicines.

Regular follow-up with your sleep service is important to review pressure settings, mask fit, and adherence data downloaded from the device.

How do I get a CPAP machine on the NHS or privately in the UK?

NHS CPAP is available free following a formal OSA diagnosis via GP referral to a sleep clinic, with no prescription charge for hospital-supplied equipment. Private diagnosis and provision are available through CQC-regulated clinics for faster access.

In the UK, CPAP machines are available through the NHS following a formal diagnosis of obstructive sleep apnoea, typically confirmed by a home cardiorespiratory sleep study or polysomnography arranged by a GP or respiratory specialist. NICE guideline NG202 recommends CPAP for adults with moderate to severe OSAHS, and it is also considered for symptomatic mild OSAHS.^[1][2] NHS sleep services provide the device, mask, and ongoing support free at the point of use; hospital-supplied CPAP equipment is not subject to NHS prescription charges.^[17]

The pathway usually begins with a GP referral to a local sleep clinic or respiratory medicine service. Waiting times vary by region, as commissioning decisions are made by local Integrated Care Boards (ICBs) in England.^[16] Some areas offer direct-access sleep testing, allowing GPs to arrange a home study without a specialist appointment first.

For those who prefer not to wait or who do not meet NHS thresholds, private diagnosis and CPAP provision are available through independent sleep clinics and some online services. Private sleep studies, consultant review, and device supply can be arranged more quickly, though costs vary and should be confirmed with the provider before proceeding. It is worth checking whether private medical insurance covers sleep apnoea investigation and treatment.

When choosing a private provider, look for services staffed by clinicians registered with the General Medical Council (gmc-uk.org) and regulated by the appropriate body for your location: the Care Quality Commission (CQC) in England, Healthcare Improvement Scotland, Healthcare Inspectorate Wales, or the Regulation and Quality Improvement Authority (RQIA) in Northern Ireland. For pharmacy services, the relevant regulator is the General Pharmaceutical Council (GPhC) in Great Britain or the Pharmaceutical Society of Northern Ireland (PSNI) in Northern Ireland. Bolt Pharmacy is a GPhC-registered UK online pharmacy offering online consultations with prescriber review and pharmacist support for a range of health conditions.

Whether accessing CPAP via the NHS or privately, ongoing follow-up and device optimisation are essential components of effective treatment.

Tips for getting the most out of your CPAP treatment

Consistent nightly use of at least four hours on 70 per cent of nights is the most important factor in achieving CPAP's health benefits. Regular mask cleaning, humidifier use, and prompt contact with your sleep service if problems arise all support long-term adherence.

Consistent nightly use is the single most important factor in achieving the full benefits of CPAP therapy. Most sleep services use a benchmark of at least four hours per night on at least 70 per cent of nights as a measure of adequate adherence, and the health benefits of CPAP are most pronounced in people who meet or exceed this threshold.^[2] Modern CPAP devices record usage data automatically, which your sleep team can review to identify patterns and troubleshoot problems.

Practical tips to improve comfort and adherence:

• Establish a routine: Use the machine every night, including naps, to build familiarity and allow your body to adapt

• Clean equipment regularly: As a general guide, wipe the mask cushion daily and clean tubing, the humidifier chamber, and the mask frame weekly, following your device manufacturer's instructions for specific intervals and methods

• Optimise your mask fit: A mask that leaks or causes pressure points will disrupt sleep and reduce therapy effectiveness. Most sleep services offer mask fitting appointments and can trial different styles

• Use the humidifier: Heated humidification reduces nasal dryness and congestion, two of the most common reasons people stop using CPAP

• Acclimatise gradually if needed: If wearing the mask feels overwhelming at first, practise wearing it while awake during the day before attempting to sleep in it

• Do not adjust pressure settings yourself: If you continue to feel unrefreshed, your partner notices ongoing snoring, or you are experiencing significant mask leaks despite good adherence, contact your sleep service to review the device data and consider a clinician-led pressure adjustment

If you are struggling with CPAP adherence, do not simply stop using the device. Contact your sleep clinic or GP for support. Many problems have straightforward solutions, and the long-term health benefits of sustained treatment make perseverance well worthwhile.

Scientific References

1. Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over 16s (NG202) – Chapter 1: Obstructive sleep apnoea/hypopnoea syndrome.
2. Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over 16s (NG202) – Rationale and impact.
3. Excessive sleepiness and driving – GOV.UK / DVLA.
4. Effect of CPAP therapy on blood pressure in patients with OSA: IPD meta-analysis (Pengo MF et al.).
5. Effect of CPAP on Blood Pressure in Patients With Obstructive Sleep Apnea and Resistant Hypertension (Martínez-García MA et al.).
6. Effects of continuous positive airway pressure on blood pressure in patients with resistant hypertension and OSA.
7. Effects of CPAP on Blood Pressure Parameter Across Different Severities of Obstructive Sleep Apnoea: A Meta-Analysis.
8. Obstructive sleep apnea in the patient with atrial fibrillation: current knowledge and remaining uncertainties.
9. Effects of continuous positive airway pressure treatment in obstructive sleep apnea patients with atrial fibrillation: A meta-analysis.
10. Benefits of continuous positive airway pressure on glycaemic control and insulin resistance in patients with type 2 diabetes and obstructive sleep apnoea: A meta-analysis.
11. Effect of Continuous Positive Airway Pressure on Glycemic Control in Patients with Obstructive Sleep Apnea and Type 2 Diabetes: A Randomized Clinical Trial.
12. Obstructive Sleep Apnea as a Risk Factor for Stroke and Death (Yaggi HK et al.).
13. Efficacy of CPAP for Improvements in Sleepiness, Cognition, Mood, and Quality of Life in Elderly Patients With OSA: Systematic Review and Meta-analysis of Randomized Controlled Trials.
14. Continuous positive airway pressure treatment for sleep apnea in elderly patients: systematic review and meta-analysis.
15. The Yellow Card scheme: guidance for healthcare professionals, patients and the public – GOV.UK.
16. Find your local integrated care board (ICB) – NHS England.
17. Sleep apnoea – NHS.

Frequently Asked Questions